GENERAL COMMENTS
I enjoyed reading this manuscript. It gives a good overall picture of what is going on. The list of comments is attached as a pdf as well as listed below:
Suggested revisions:
In the abstract (line 25) the abbreviation LA is used without an explanation
Response rate section (lines 88-93) -The overall response rate 146/152 is followed by usable responses (127 and 17) does this mean two of the responses were un-usable? If so why? -Lines 91-92, for a reader it might be clearer if the sentence is started with the number of LAs failing to provide usage data before explaining how much of this information the authors were able to identify from PharmOutcomes and Service PACT.
In table 3, column titled "Range across LAs, where provided" I am unclear on what the percentage that is given represents? Also in the column caption comma (,) is used whereas within the column dash (-) is used.
Consistency in results and discussion with n= and % -P. 8 line 5, n is missing for the 47% -p. 8 line 8, n is missing for the 26% -p. 8 line 42, % is missing for 16 out of 61 and n missing for 50% -p. 8 line 46, % is missing for 14 out of the 30 -p. 9 line 51, n is missing from 91% -p.9 line 52, n is missing from 58% Table 4 p. 9 the last line of the table is out of synch with the columns.
Reference 12 is missing the journal name.
Points for consideration but not necessarily revision: Title identifies the study observational study and in the abstract it is further specified as a cross-sectional study. There was no mention of checking the article against STROBE checklist for cross-sectional studies. Was this considered or was another guideline used to ensure the study write up covers the areas an observational study should?
Just a pondering as I was reading the comparison to the population data section: Could a potential weakness in this study with correlations to relevant population health for the areas that were providing services even though they were below average be that the study only looked at the data for one year? It could be that in the previous years there had been a higher need and thus services were commissioned which would not be reflected in the snap shot provided by one year. Would the relationship of the provided services with the provision be better looked at longitudinally?
Continuing on with the correlations of provision and population health. It was interesting to see that there seemed to be definite clustering on the correlation graphs for chlamydia screening, supervised consumption and needle exchange whereas for the other services the correlations were very dispersed. Is the prevalence of new STIs and substance misuse deaths relatively similar across the LAs nationally?
Introduction
Although commissioning of pharmacy services is recognised to be complicated, it is not necessarily complex to describe. It would be helpful, especially for the international audience, that a brief picture of commissioning is presented clearly as not to distract from the important point that there are variations within service provision. One suggested way is that there is an initial explanation of how pharmaceutical services are delivered alongside other professional commissioned services followed by a clearer description of pharmacy service commissioning i.e.
• NHS England commissions provision of NHS pharmaceutical services through the English Community Pharmacy Contractual Framework (CPCF) consisting of 3 "tiers" of service.
• Commissioning services from Local Authorities.
• Less common Local Pharmaceutical Services (LPS) Contracts
• Services commissioned from CCGs (details available from PSNC)
There are few details in the introduction as to why there is this drive to deliver more public health interventions to help promote health and wellbeing in the wider population. The readership may welcome more context here. For example, other than pharmacy accessibility, the paper would benefit from detail of people who are hard to reach. Who are these individuals and why are they under-served? By explaining the factors that are influencing public health policy a good case can be built for then looking at variations in services; which is what the paper is about.
It would also be helpful to mention the range of other providers available (i.e. GP surgeries, walk-in centres) and talk about their accessibility. This is useful as the study did not investigate these, and the audience may wonder about the range of providers and and their present commissioning role.
On a separate note, it would be handy to give the reader a brief description of which services / outcomes commissioners encourage pharmacists to submit data to the national database (PharmOutcomes).
Methods
Line 50: In the FOI request, what were the "key details" that were asked for?
Line 52: Why was a shorter request sent as a follow-up?
Line 54-55: It would be helpful if the reporting relationship with Service PACT (Webstar Health Limited) is described more fully here (reporting to PharmaOutcomes is made clear in the introduction).
It may be that some services will be co-commissioned e.g. also from GP practice (i.e. vaccination services). It would be helpful if the authors could detail why they chose not to investigate other providers as this would have given a more complete picture.
Ethics
Although approval by a Research Ethics Committee would not be necessary (as no patients, users or carers were involved) can the authors clarify whether they sought HRA governance approval and if this was needed?
Results I may be missing something but the overall response rate is reported as being 144 of the 148 commissioning authorities (97.3%). I am slightly confused by the next paragraph (Line 91). Where have the numbers "14 of the 26 LAs which failed to provide any data on usage" arisen from? Does this mean that the LA responded but provided no data on service usage?
Line 97: perhaps clarify "services to people who use drugs"? as to which service is being referred to?
Line 101: Can you explain who the third parties were who commissioned service indirectly?
Line 36-48: For me, the "Comparison to population health data" is the most interesting section, but I feel it could be unpacked and explained more clearly. The first example provided (line 39) states, "14 LAs did not report a commissioned pharmacy smoking cessation service, seven of which had adult smoking rates above the national average" Did 14 LA not report or did not have? Is this 14 / 146 LA is actually less than 10%. So is this saying 90% of LA did in fact have good provision of service?
In the same sentence (Line 42) it states "while in 16 out of 61 other LAs with above average smoking rates, fewer than 50% of pharmacies provided a service". That tells us that 50% of pharmacies were providing a smoking cessation service, but it"s not clear (here and throughout) if other providers in these LA were also providing this service. If they were, the service may not actually be needed from community pharmacies?
If this section can be unpacked somewhat it would be very helpful.
Discussion
Line 24: I'm not sure about the point that commissioning of public health services in pharmacies is "highly variable". We are told in the next sentence that 3 out of 4 services mentioned, are "available in at least 45% of all pharmacies". This does not tell me about variability; perhaps to make the point provide the range here?
Line 41: Can the authors explain briefly why the study did not attempt to seek information on services commissioned by CCGs or those provided under the national community pharmacy contractual framework or minor ailment service. This is stated in the limitation at the beginning which is fine, but I would have thought be quite relevant to support the study"s findings.
Minor issues
Introduction
Line 6: Consider using the term "seldom heard" or under-served as the term "hard to reach" suggest that there is something that prevents peoples" engagement with services (whereas "seldom heard voices" emphasises the responsibility of agencies to reach out to excluded people). -Title identifies the study observational study and in the abstract it is further specified as a crosssectional study. There was no mention of checking the article against STROBE checklist for crosssectional studies. Was this considered or was another guideline used to ensure the study write up covers the areas an observational study should? o As described above, in response to the editor"s comments, a STROBE checklist has been included with the resubmitted manuscript -Just a pondering as I was reading the comparison to the population data section: Could a potential weakness in this study with correlations to relevant population health for the areas that were providing services even though they were below average be that the study only looked at the data for one year? It could be that in the previous years there had been a higher need and thus services were commissioned which would not be reflected in the snap shot provided by one year. Would the relationship of the provided services with the provision be better looked at longitudinally? o We thank the reviewer for these observations and have addressed this in the study limitations section (Page 10, lines 242-245) -Continuing on with the correlations of provision and population health. It was interesting to see that there seemed to be definite clustering on the correlation graphs for chlamydia screening, supervised consumption and needle exchange whereas for the other services the correlations were very dispersed. Is the prevalence of new STIs and substance misuse deaths relatively similar across the LAs nationally?
o The apparent clustering on the graphs for STIs and substance use related deaths is simply a result of outliers in the data, which led to the majority of data points being compressed to the left-hand side of the figure. If these outliers are removed, the resulting distributions become much more comparable to the other charts.
Reviewer: 2 -Abstract: consider redrafting in light of the comments below.
• We have made appropriate changes to the abstract to correspond to the changes outlined elsewhere in this document.
Introduction -Although commissioning of pharmacy services is recognised to be complicated, it is not necessarily complex to describe. It would be helpful, especially for the international audience, that a brief picture of commissioning is presented clearly as not to distract from the important point that there are variations within service provision. One suggested way is that there is an initial explanation of how pharmaceutical services are delivered alongside other professional commissioned services followed by a clearer description of pharmacy service commissioning i.e.
• Less common Local Pharmaceutical Services (LPS) Contracts • Services commissioned from CCGs (details available from PSNC)  We have included additional details regarding how services might be commissioned from community pharmacies, (Page 3, Lines 62-69) but have not explored the delivery of pharmaceutical services in the text as this is beyond the scope of this paper, which is focussed on the commissioning of public health services, rather than how they are delivered within any given pharmacy.
-There are few details in the introduction as to why there is this drive to deliver more public health interventions to help promote health and wellbeing in the wider population. The readership may welcome more context here. For example, other than pharmacy accessibility, the paper would benefit from detail of people who are hard to reach. Who are these individuals and why are they underserved? By explaining the factors that are influencing public health policy a good case can be built for then looking at variations in services; which is what the paper is about.
• We believe that this is quite a well-rehearsed argument and there are multiple papers and policy documents that set out the case for community pharmacy being a provider of public health services, which was first mooted over 30 years ago. References 1-7 present a comprehensive and detailed argument for this and we feel that it would make the paper less engaging to re-visit these arguments in any great depth.
-It would also be helpful to mention the range of other providers available (i.e. GP surgeries, walk-in centres) and talk about their accessibility. This is useful as the study did not investigate these, and the audience may wonder about the range of providers and and their present commissioning role.
• As above, we believe that this is outside the scope of this paper, which is focussed on the variation in commissioning of services from community pharmacy, rather than the relative merits, or otherwise, of such services being commissioned. However we have emphasised that our study did not cover other providers of services in the study limitations section.
-On a separate note, it would be handy to give the reader a brief description of which services / outcomes commissioners encourage pharmacists to submit data to the national database (PharmOutcomes).
• Our focus was on the numbers of pharmacies commissioned, the services they were providing and the number of service episodes completed, and thus that is where our efforts were focussed during data collection. As the detailed data reporting requirements were beyond this scope of this study, we do not have complete information on this point and these requirements are not in the public domain, so extensive additional work would be required to attempt to obtain a useful dataset regarding this point.
-Line 6: Consider using the term "seldom heard" or under-served as the term "hard to reach" suggest that there is something that prevents peoples" engagement with services (whereas "seldom heard voices" emphasises the responsibility of agencies to reach out to excluded people).
• We have changed the text to refer to "under-served" groups (Page 3, line 60)
- Table 2 & 3: suggest services are placed in some logical order (perhaps ascending or descending number offering the service) to ease interpretation.
• The services have been clustered into broad groupings -this has been clarified with revisions to the tables/figure to make this more explicit (Table 2 & Figure 1 ).
-Perhaps consider presentation where appropriate by bar-graph to ease interpretation of results.
• We have reflected on the data presentation and have decided to transfer some of this Table 2 into a graphical format (Figure 1 ). If the editorial team prefer this presented as a table, we are happy to revert to the original format.
Methods -Line 50: In the FOI request, what were the "key details" that were asked for? o The details related to all aspects of the public health services that they commissioned from community pharmacies, including service descriptors, numbers of pharmacies commissioned and usage statistics, i.e. the data reported in the paper. (Page 4, Line 112-113).
-Line 52: Why was a shorter request sent as a follow-up? o As the LA failed to respond to the first request, a more focussed request was sent the second time around to maximise the possibility for a response being given -this has been clarified in -It may be that some services will be co-commissioned e.g. also from GP practice (i.e. vaccination services). It would be helpful if the authors could detail why they chose not to investigate other providers as this would have given a more complete picture. o Owing to the complexities of the commissioning landscape for community pharmacy services, this paper only explores the services that are commissioned by local authorities -services commissioned through other mechanisms are outside of this scope. The scope is set out in the study aim ( -Line 36-48: For me, the "Comparison to population health data" is the most interesting section, but I feel it could be unpacked and explained more clearly. The first example provided (line 39) states, "14 LAs did not report a commissioned pharmacy smoking cessation service, seven of which had adult smoking rates above the national average" o As this is a proxy comparator, using a cross sectional data set, we are mindful that it would be easy to overstretch the appropriateness of this analysis and have restricted our analysis to simple comparisons between the commissioning of services and a relevant health marker related to the service. We do not feel that it would be appropriate to extend the analysis and "unpack" this further.
-Did 14 LA not report or did not have? Is this 14 / 146 LA is actually less than 10%. So is this saying 90% of LA did in fact have good provision of service? o We can only describe what was reported as we did not measure services directly. The point being made is that services were not commissioned where there appeared to be a health need in the local population profiles. Whilst 90% did have a service, the health need for this varied across each authority area.
-In the same sentence (Line 42) it states "while in 16 out of 61 other LAs with above average smoking rates, fewer than 50% of pharmacies provided a service". That tells us that 50% of pharmacies were providing a smoking cessation service, but it"s not clear (here and throughout) if other providers in these LA were also providing this service. If they were, the service may not actually be needed from community pharmacies? o We agree that this is a possibility and the lack of data on the totality of service provision is a limitation of the study (see Page 10, Lines 239-245), but as we focussed on community pharmacy provision, we can only comment on the relationship between the pharmacy service commissioning and the apparent health need locally.
-If this section can be unpacked somewhat it would be very helpful. o As described above, we feel that the extent to which we have "unpacked" this aspect of the study is appropriate within the constraints of the data, but to take it further than this may result in a misrepresentation of the true situation.
Discussion -Line 24: I'm not sure about the point that commissioning of public health services in pharmacies is "highly variable". We are told in the next sentence that 3 out of 4 services mentioned, are "available in at least 45% of all pharmacies". This does not tell me about variability; perhaps to make the point provide the range here? o We have revised the text to make clearer that the second sentence is a making a different point, rather than illustrating the point made in the first sentence (Page 9, line 213-215).
-Line 41: Can the authors explain briefly why the study did not attempt to seek information on services commissioned by CCGs or those provided under the national community pharmacy contractual framework or minor ailment service. This is stated in the limitation at the beginning which is fine, but I would have thought be quite relevant to support the study"s findings. o The focus of the paper was on LA commissioning as this is where the core responsibility for public health service provision rests following the Health and Social Care Act. This fact has now been clarified in the introduction (Page 3, Lines 65-67).
References -There are some recent references that could be included i.e. Pharmacy in England: building on strengths -delivering the future which might be more relevant than reference 2. Likewise reference 1 & 3 are quite dated. o We thank the reviewer for this suggestion and have replaced reference 2 with Pharmacy in England: building on strengths -delivering the future. o References 1 & 3 were deliberately included to illustrate the long-standing background to the arguments for community pharmacy to play a role in public health provision.
Reviewer: 3 -I suggest making clearer the time frame that data refers to, ie, when collecting information on number of screens, it is in some sections nuclear, if the number mentioned refers to lifetime, year, month, etc. (see table 1 -There are minor typing errors, which should be reviewed. o We have proof read the revised paper for errors and corrected any that we identified.
-It is unclear to me why population data was only sought for some services and not others (e.g. immunisation coverage). Explanation of correlations and meanings could be improved. I don't see any table clearly showing the variations across the country, which I expected Reading the abstract. o The health need data were taken from the available data sets on the Public Health England data and analysis tools website (Page 5, Line 130-131). We selected the most closely linked data available, but in some cases, there were no appropriate data that could be used as a proxy measure for health need relating to the services in question. We have carried out this analysis for all the most frequently commissioned services. The actual correlations explored are explicitly stated in text and full details are given in Additional datafile 3. o Variation across local authorities in the proportions of pharmacies commissioned to provide services are shown in column 5 of Reviewer: 4 -The main finding of this study is the variation in commissioning and delivery of public health services in community pharmacies across England. This conclusion should be supported with a proper statistical analysis.
o Our data are largely descriptive and, we believe, clearly demonstrate a variation in commissioning, with a wide range in all of: the specific services commissioned; the numbers of services being commissioned in each local authority; the proportion of pharmacies commissioned to provide services within a local authority. We undertook some basic statistical analysis to explore whether there was any relationship between proxy measures of health need and service provision and found no relationships (practical/clinical or statistical). We believe that the above clearly demonstrates variation in commissioning and are unclear what additional statistical analysis could be undertaken to demonstrate that variation exists.
-Pearson correlation coefficient was used to explore correlations between services and potential needs. However, other nonlinear relationships may have been overlooked. o We are unclear what the hypothesis would be to underpin any analysis of a non-linear relationship. It would not be logical to hypothesise that service commissioning would rise with increasing health need, then fall as the need rose further. Neither would a logarithmic or other more complex relationship be logical. In our view, the only logical hypothesis to test is that as the proxy measure indicates an increased health burden, it is reasonable to expect the corresponding commissioning of services related to this health need to increase. In the absence of a sensible hypothesis, we do not feel it appropriate to undertake further analyses as this carries a significant risk of a false positive result. 
VERSION 2 -REVIEW REVIEWER

GENERAL COMMENTS
All items marked as 3no3 are detailed below.
The paper greatly improved in clarity after the first revision. This is undoubtedly a paper of great interest because it presents valuable data unavailable elsewhere. Nonetheless, I think there are still aspects that could benefit from additional clarity. These are summarized and referred to below:
Abstract: the conclusion presented refers to data unavailable in the results. I would suggest either rephrasing the conclusion or adding such data in the abstract in a quantifiable manner.
It is unclear why at the abstract only 6 services commissioned are mentioned and then only 4 when referring to services offered. Later on, in the manuscript, there are 10 services mentioned in the introduction (line 97-102), figure 1 refers 15 services and table 2 refers to 13 services. Perhaps especially for non-English readers this is very confusing as they may not have information on the full scope of services available in the UK.
In the introduction, the authors explain the databases used and later on refer to FOI; again this is not so unclear for international readers. It would be interesting to briefly explain the concept so that every reader understands under which conditions these databases are available. Table 1 presents the definitions used for service estimation but it is unclear if these were chosen by the authors based on their rational or if these are the unit measures adopted for remuneration purposes within the contract. The main reason for this comment is that the unit measures are chosen in a heterogeneous manner in my opinion, as some consider the service as the unit of measurement (e.g. supervised consumption), others consider the individual person (who can receive various units of the service measured as consultation/delivery; e.g. smoking cessation) and others consider both (e.g. vitamin supply). This fact has obvious implications on the results later presented in table 2 and should therefore at least be justified.
In line 136, the authors explain the use of proxy measures of health need but presents these only for 6 services without justifying why proxy measures were not considered for the remaining services.
Until this point of the manuscript, the authors refer to different services up to a total of 15 (maximum), but on line 158 and later in line 237 mention 833 services being commissioned expressing themselves in the same manner, so I don"t understand what this value reports to. Is this the total number of service units commissioned? In table 2, the first column presents such data; however, when adding up values reported you only get to 810. Can this aspect please be clarified?
There is some inconsistency with the way services are referred to in different tables and figures. For example, figure 1 mentions emergency contraception whereas table 2 refers to EHC, standing for emergency hormonal contraception (and in some countries mentioned as EOC, emergency oral contraception), so I would suggest using the same way to describe regardless of using the acronym or the name in full; same applies to vitamin supply. Table 2 (oral contraception) in first column presents only the number and not the %. In this table, there are several cells with the mention n/a but it is not explained why it is not applicable; my understanding is that if there is more than 1 LA, it is always possible to present the range of pharmacies providing the service. Is this interpretation not correct?
Also, I find that figure 1 does not exactly add much to table 2 (first column) and its information could eventually be included in this table. The column "total service episodes" includes information that refers to users and not episodes, unless explained otherwise, as referred previously.
My main concern/question on the manuscript refers to the analysis presented in table 3. This concern results from various aspects, which I will mention with no specific order:
One of the variables used is "services commissioned", but the previous table has shown that services may be commissioned and not be provided. Also, the manuscript mentions that services may be commissioned elsewhere. So, how valid is this measure? Would the authors get the same results if they used "services provided" rather than "services commissioned"? -Another issue is the indicators chosen for health need. To what extent are these valid and appropriate? The fact that the same indicator "death from substance use" was chosen for 2 services with such distinct purposes as NSP and supervised consumption triggers this concern. Another example is "health checks", which intend to detect undiagnosed diseases, so if the prevalence of a given disease is higher doesn"t that mean that the disease is unlikely/less likely to be underdiagnosed in that area? On the other hand, the indicator cardiovascular mortality is an indicator which would be interesting to use, mostly if longitudinal data was possible to collect. I would assume that if the service is commissioned and provided then, on the long term, this indicator would diminish. However, the study is cross-sectional and although data from previous years was available (line 258 onwards), it was not used. Could you not use this data for this purpose? Finally, the table where this data is presented is out of format. And a parametric test of correlation was used where no warranty of normality distribution was given.
The fact that the services are commissioned but not necessarily provided is worrying and interesting. Theories of early and late adopters (both regarding commissioners and pharmacies commissioned) could be used to help explain these findings and should be mentioned.
Even though the acronyms have been previously explained, and BMJ is British, as it is read worldwide I would advise reviewing lines 261 to 268 as in only 7 lines 10 acronyms have been used and the reading becomes very difficult. In this same paragraph, some sections use absolute values and others use percentages; when absolute values are used without mention of the total, it is not possible to understand the meaning of the value presented, so I would advise adopting percentages throughout the entire paragraph.
VERSION 2 -AUTHOR RESPONSE
Abstract: the conclusion presented refers to data unavailable in the results. I would suggest either rephrasing the conclusion or adding such data in the abstract in a quantifiable manner. The abstract has been modified to add in further data. Text has been changed to maintain the word limit.
It is unclear why at the abstract only 6 services commissioned are mentioned and then only 4 when referring to services offered. Abstract has been modified to explain that additional services were commissioned. As these were very few in number no specific information is mentioned in the abstract.
Later on, in the manuscript, there are 10 services mentioned in the introduction (line 97-102), figure 1 refers 15 services and table 2 refers to 13 services. Perhaps especially for non-English readers this is very confusing as they may not have information on the full scope of services available in the UK. The text mentioned is prefaced by the word including, hence the list here is not meant to be comprehensive. Fig 1 includes 14 services plus "others" (hence 15 data points). These other services are included in Additional datafile 1, from which it can be seen that these were commissioned by very few LAs (fewer than 5). Table 2 excludes flu vaccination, as few data were available on number of service episodes. Text has been added to methods explaining this. The very small scale services (each commissioned by fewer than 5 LAs) were also not included in Table 2 .
In the introduction, the authors explain the databases used and later on refer to FOI; again this is not so unclear for international readers. It would be interesting to briefly explain the concept so that every reader understands under which conditions these databases are available.
The FOI Act has been referred to in the introduction and clarification given regarding the accessibility of the databases mentioned. Table 1 presents the definitions used for service estimation but it is unclear if these were chosen by the authors based on their rational or if these are the unit measures adopted for remuneration purposes within the contract. The main reason for this comment is that the unit measures are chosen in a heterogeneous manner in my opinion, as some consider the service as the unit of measurement (e.g. supervised consumption), others consider the individual person (who can receive various units of the service measured as consultation/delivery; e.g. smoking cessation) and others consider both (e.g. vitamin supply). This fact has obvious implications on the results later presented in table 2 and should therefore at least be justified. The definitions were based on those most frequently used for remuneration purposes, however we are aware that there is also variation in these measures.
In line 136, the authors explain the use of proxy measures of health need but presents these only for 6 services without justifying why proxy measures were not considered for the remaining services. We addressed this issue in our responses to previous reviewer comments. The health need data were taken from the available data sets on the Public Health England data and analysis tools website. We selected the most closely linked data available, but in some cases, there were no appropriate data that could be used as a proxy measure for health need relating to the services in question. We have carried out this analysis for all the most frequently commissioned services. For other services, there are too few data to warrant such analysis.
The reviewer is correct in that there were a total of 833 services commissioned by the 148 LAs, which are shown in Table 2 . However as Table 2 omits flu vaccination (13) and the very small scale services put together as "others" (10), the data in Table 2 add to 810 services. We believe that this has been clearly described in the text and are unable to clarify further.
There is some inconsistency with the way services are referred to in different tables and figures. For example, figure 1 mentions emergency contraception whereas table 2 refers to EHC, standing for emergency hormonal contraception (and in some countries mentioned as EOC, emergency oral contraception), so I would suggest using the same way to describe regardless of using the acronym or the name in full; same applies to vitamin supply. We have amended the manuscript in a number of places to address this point. Table 2 (oral contraception) in first column presents only the number and not the %. The proportion has now been added.
In this table, there are several cells with the mention n/a but it is not explained why it is not applicable; my understanding is that if there is more than 1 LA, it is always possible to present the range of pharmacies providing the service. Is this interpretation not correct? n/a is used wherever there is available data from only 1 LA, which as the Table shows is the case for oral contraception and TB services.
Also, I find that figure 1 does not exactly add much to table 2 (first column) and its information could eventually be included in this table. Table 2 is already large and complex and we do not believe it would be desirable to combine the data. Moreover, a previous reviewer requested that these data be presented in graphic form.
The column "total service episodes" includes information that refers to users and not episodes, unless explained otherwise, as referred previously. Heading for Table 2 has been changed to service use for consistency.
-One of the variables used is "services commissioned", but the previous table has shown that services may be commissioned and not be provided.
-Also, the manuscript mentions that services may be commissioned elsewhere. So, how valid is this measure? Would the authors get the same results if they used "services provided" rather than "services commissioned"? Our request to local authorities was for services commissioned, therefore these are the data we were able to use for this analysis. While it may be the case that services provided may show a different pattern, it does not affect our argument which is that service commissioning should reflect need.
-Another issue is the indicators chosen for health need. To what extent are these valid and appropriate? The fact that the same indicator "death from substance use" was chosen for 2 services with such distinct purposes as NSP and supervised consumption triggers this concern.
As stated previously and in response to earlier reviewer comments, the health need data were taken from the available data sets on the Public Health England data and analysis tools website. We selected the most closely linked data available, but in some cases, there were no appropriate data that could be used as a proxy measure for health need relating to the services in question. With respect to the particular point made about substance use services, both interventions (supervised consumption and NSP) are part of a harm reduction package intended to reduce harm associated with injecting drug use and maximise the use of sterile and appropriate equipment for the remaining injections that do take place. Injecting drug use is a major contributor to death from substance use and we believe it appropriate to use this measure as a proxy for the need for harm reduction services.
Another example is "health checks", which intend to detect undiagnosed diseases, so if the prevalence of a given disease is higher doesn"t that mean that the disease is unlikely/less likely to be underdiagnosed in that area?
We have recognised that the measures are a proxy of need, not a direct measure. In this particular case, the indicator used was cardiovascular mortality, which suggests that there is a need for earlier diagnosis to prevent deaths, hence NHS Health Checks are needed more in areas with higher mortality.
On the other hand, the indicator cardiovascular mortality is an indicator which would be interesting to use, mostly if longitudinal data was possible to collect. I would assume that if the service is commissioned and provided then, on the long term, this indicator would diminish. However, the study is cross-sectional and although data from previous years was available (line 258 onwards), it was not used. Could you not use this data for this purpose?
We have responded to a previous reviewer on this question and ensured that it is mentioned as a limitation in the manuscript text: "the cross-sectional nature of the study and the corresponding data on health need means that it is not possible to fully describe the relationship between the two. However, the intention of including these data is to illustrate the disconnect between the apparent health need and the provision of services through community pharmacies and not to suggest any causative relationship."
Finally, the table where this data is presented is out of format. We have managed to correct this issue in the revised version.
And a parametric test of correlation was used where no warranty of normality distribution was given. Thank you for this observation. The correlations have been revised using Spearman"s correlation coefficient -this has not fundamentally changed any of the conclusions drawn.
We have no data to justify any speculation about why service delivery varies and, in the absence of such data, do not consider it appropriate to do so in this paper.
Even though the acronyms have been previously explained, and BMJ is British, as it is read worldwide I would advise reviewing lines 261 to 268 as in only 7 lines 10 acronyms have been used and the reading becomes very difficult. We have removed two of the acronyms and replaced one with alternative text and written one out in full. The remaining acronyms are repeated EHC and NSP, which are internationally used. If the editors feel that these should be replaced to aid understanding, we are happy for this to be done (either by the authors, or as part of the production editing).
In this same paragraph, some sections use absolute values and others use percentages; when absolute values are used without mention of the total, it is not possible to understand the meaning of the value presented, so I would advise adopting percentages throughout the entire paragraph. The numbers quoted are from other work, which did not provide any denominators in terms of the number of commissioning local authorities. While there are 152 authorities, our study has found that not all commission services themselves. Therefore we do not feel it appropriate to add proportions to these data. 
GENERAL COMMENTS
The manuscript has greatly improved in clarity of language. My only additional suggestion would be to have a minor comment on the negative correlations shown.
VERSION 3 -AUTHOR RESPONSE
We thank the reviewer for further suggestion and have added comments in the Discussion section to address this. We trust the manuscript now addresses all the issues raised.
